Jul 17, 2026 07:00AM

Jul 17, 2026 07:00AM

Jul 16, 2026 04:27PM

Jul 16, 2026 04:26PM

Mar 5, 2026 02:52PM

Aug 28, 2025 07:05AM

Jun 5, 2025 01:21PM Morgan Stanley on Regenxbio Inc. (RGNX): 'we continue to appreciate RGNX’s diversified mid- to late-stage gene therapy pipeline'

Nov 15, 2024 03:19AM

Aug 29, 2024 04:05PM

Mar 6, 2024 11:40PM

Mar 6, 2024 11:20PM

Mar 6, 2024 04:11PM

Mar 6, 2024 04:10PM

Sep 5, 2023 07:05AM REGENXBIO to Participate in Upcoming Investor Conferences

Sep 6, 2022 07:05AM

Mar 9, 2022 07:05AM

Oct 19, 2021 08:10AM

Sep 14, 2021 08:57AM

Sep 7, 2021 04:05PM

Feb 24, 2021 04:05PM

Jan 19, 2021 02:41AM Regenxbio Inc. (RGNX) PT Raised to $67 at Morgan Stanley

Jan 12, 2021 04:05PM

Jan 8, 2021 07:06AM

Jan 8, 2021 07:05AM

Jan 6, 2021 04:01PM

Jan 6, 2021 04:01PM

Dec 22, 2020 04:21PM

Dec 22, 2020 04:19PM REGENXBIO Announces Agreement to Monetize Portion of Zolgensma® Royalties for $200 Million

Sep 17, 2020 08:12AM

Sep 2, 2020 04:05PM

Aug 28, 2019 04:05PM

Aug 9, 2019 08:52AM

Jul 15, 2019 09:00AM

Mar 6, 2019 07:00AM

Sep 6, 2018 04:05PM REGENXBIO to Present at Upcoming Investor Conferences

Aug 14, 2018 04:01PM

Aug 10, 2018 07:31AM

Aug 10, 2018 07:30AM

Aug 8, 2018 04:55PM

Aug 8, 2018 04:05PM

Jul 13, 2018 09:41AM

Mar 14, 2018 07:11AM Regenxbio Inc. (RGNX) PT Lowered to $35 at Morgan Stanley

Mar 7, 2018 04:05PM

Mar 7, 2018 04:05PM

Nov 9, 2017 05:52AM

Aug 31, 2017 07:00AM

Aug 25, 2017 08:01AM

Aug 25, 2017 08:00AM

Apr 26, 2017 04:01PM REGENXBIO Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares

Mar 22, 2017 09:24AM

222,342 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All